In this study, we demonstrated that BCKDK was overexpressed in both clinical breast cancer specimens and breast cancer cell lines and that its expression was higher in triple-negative breast cancer with a high degree of malignancy and metastasis. Here, BCKDK is linked to triple-negative breast carcinoma.